Drug
|
Date
|
Indication
|
Remark
|
| Nivolumab |
March 4, 2015 |
Advanced (metastatic) squamous non-small cell lung cancer (NSCLC) |
Expanded use |
| Filgrastim biosimillar |
March 6, 2015 |
First biosimilar product approved to stimulate the proliferation and differentiation of granular |
First biosimilar |
| Isavuconazonium sulfate |
March 6, 2015 |
Invasive aspergillosis and invasive mucormycosis |
A new antifungal drug |
| Dinutuximab |
March 10, 2015 |
First-line therapy for pediatric patients with high-risk neuroblastoma |
With Boxed warning |
| Cholic acid |
March 17, 2015 |
Rare bile acid synthesis disorders |
|
| Anthrax immune globulin intravenous |
March 25, 2015 |
Inhalational anthrax |
In combination with appropriate antibiotic drug |
| Aflibercept |
March 25, 2015 |
Diabetic retinopathy in patients with diabetic macular edema. |
Expanded use |
